| Sign In to gain access to subscriptions and/or personal tools. |
TACE mRNA expression in peripheral mononuclear cells precedes new lesions on MRI in multiple sclerosisDepartment of Neurology, Karl Franzens University, Auenbruggerplatz 22, Graz A-8036, Austria, thomas.seifert{at}kfunigraz.ac.at
Department of Neurology, Karl Franzens University, Auenbruggerplatz 22, Graz A-8036, Austria
MRI Center, Karl Franzens University, Auenbruggerplatz 22, Graz A-8036, Austria
Department of Neurology, Karl Franzens University, Auenbruggerplatz 22, Graz A-8036, Austria
Institute for Medical Informatics, Statistics and Documentation, Karl Franzens University, Engelgasse 13, Graz A-8010, Austria
Department of Neurology, Karl Franzens University, Auenbruggerplatz 22, Graz A-8036, Austria, MRI Center, Karl Franzens University, Auenbruggerplatz 22, Graz A-8036, Austria
Department of Neurology, Karl Franzens University, Auenbruggerplatz 22, Graz A-8036, Austria Tumor necrosis factor-a (TNF-a) is involved in the pathogenesis of multiple sclerosis (MS). It has to be released from its cell membrane-bound precursor by proteolytic cleavage. This is mainly performed by a member of the ADAM (a disintegrin and metalloproteinase) family of enzymes, TNF-a-converting enzyme (TACE, ADAM 17). In a longitudinal study on 11 relapsing-remitting MS patients, we qualitatively determined mRNA expression of TNF-a and TACE in peripheral blood mononuclear cells (PBMCs) without ex vivo stimulation. mRNA expression was related to disease activity as assessed by monthly gadolinium (Gd)-enhanced brain magnetic resonance imaging (MRI). Patients found positive for TACE mRNA in PBMCs showed a significantly higher mean number of new Gd-enhancing lesions per scan one month following PBMC sampling.
Key Words: multiple sclerosis TACE TNF-
Multiple Sclerosis, Vol. 8, No. 6,
447-451 (2002) This article has been cited by other articles:
|
|||||||||||||||

